Heron Therapeutics Inc (HRTX)

EBITDA Growth

-507.03%

TTM · Period ending:

HRTX logo

HRTX EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-507.03%
HRTX TTM EBITDA YoY % (-43.90% → -507.03%)
High-resolution chart · PNG

HRTX ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Heron Therapeutics Inc EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
-442.5743%
-923.1788%
-297.027%
-146.5649%
-125.25%
-85.2683%
-41.5789%
9.1667%
150%
485.7143%
280%
400%
172.7273%
120.5882%
117.8571%
89.0411%
71.0526%
56.962%
22.2222%
-32.7273%
-18.75%
-9.7222%
12.1951%
40.8602%
28.8889%
20.8791%
12.766%
-5.6818%
-26.7606%
-71.6981%
-77.3585%
-95.5556%
-47.9167%
-26.1905%
-60.6061%
-40.625%
-45.4545%
-5%
13.1579%
17.9487%
10.8108%
-5.2632%
-52%
58.0645%
52.5641%
39.6825%
57.6271%
-200%
-129.4118%
-80%
-43.9024%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.